HEPA logo

HEPA
Hepion Pharmaceuticals Inc

26,968
Mkt Cap
$720,460.00
Volume
102,961.00
52W High
$1.17
52W Low
$0.033
PE Ratio
-0.03
HEPA Fundamentals
Price
$0.062
Prev Close
$0.06
Open
$0.045
50D MA
$0.0507
Beta
0.71
Avg. Volume
6,080.53
EPS (Annual)
-$0.8797
P/B
0.74
Rev/Employee
$0.00
$0.4857
Loading...
Loading...

About

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate, Rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Morristown, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2

Frequently Asked Questions

What is Market Cap of Hepion Pharmaceuticals Inc?
What is the 52-week high for Hepion Pharmaceuticals Inc?
What is the 52-week low for Hepion Pharmaceuticals Inc?
What is Hepion Pharmaceuticals Inc stock price today?
What was Hepion Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Hepion Pharmaceuticals Inc?
What is the Price-to-Book ratio of Hepion Pharmaceuticals Inc?
What is the 50-day moving average of Hepion Pharmaceuticals Inc?
How many employees does Hepion Pharmaceuticals Inc have?

Latest HEPA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.